Phase I–II study of multiple daily fractions for palliation of advanced head and neck malignancies
Authors:
- William J. SpanosWSWilliam J. Spanos
- Robert D. LindbergRLRobert D. Lindberg
- Baby JoseBJBaby Jose
- Frederick AlbrinkFAFrederick Albrink
- 1 March 1993
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 25 (4) , 657-660
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Continuous Infusion High-Dose Leucovorin with 5-Fluorouracil and Cisplatin for Untreated Stage IV Carcinoma of the Head and NeckAnnals of Internal Medicine, 1990
- Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: Final report of rtog phase I/II studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1987
- Dose fractionation, dose rate and iso-effect relationships for normal tissue responsesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationshipsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancerCancer, 1981
- The adjuvant treatment of inoperable stage III and IV epidermoid carcinoma of the head and neck with platinum and bleomycin infusions prior to definitive radiotherapy: An RTOG pilot studyCancer, 1980
- Treatment of Previously Untreated Stage III and IV Squamous Cell Carcinoma of the Head and NeckOtolaryngologic Clinics of North America, 1980
- Whole pelvis megavoltage irradiation with single doses of 1000 rad to palliate advanced gynecologic cancersInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1979